Ascendis Health Limited (JSE:ASC)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 92.00
0.00 (0.00%)
Inactive · Last trade price on Nov 28, 2025
Ascendis Health Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
575.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 1.47B | -63.39M | -4.13% |
| Jun 30, 2023 | 1.54B | -24.02M | -1.54% |
| Jun 30, 2022 | 1.56B | -266.01M | -14.57% |
| Jun 30, 2021 | 1.83B | -377.56M | -17.14% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAscendis Health News
- 4 weeks ago - Ascendis Wins FDA Approval For Rare Disease Therapy - Benzinga
- 5 weeks ago - Ascendis (ASND) Q4 2025 Earnings Call Transcript - The Motley Fool
- 2 months ago - Ascendis Confirms Durable Growth Benefits In Achondroplasia In COACH Trial - Nasdaq
- 4 months ago - Ascendis (ASND) Q3 2025 Earnings Call Transcript - The Motley Fool
- 7 months ago - Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025 ... - GuruFocus
- 8 months ago - Ascendis (ASND) Q2 2025 Earnings Call Transcript - The Motley Fool
- 1 year ago - Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term - Benzinga